Core Scientific (NASDAQ:CORZ) Stock Falls 7.4% Following Insider Selling

Core Scientific, Inc. (NASDAQ:CORZ) shares traded down 7.4% during mid-day trading on Wednesday after an insider sold shares in the company. The stock traded as low as $14.46 and last traded at $14.2860. Approximately 2,120,247 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 12,457,098 shares. The stock had previously closed at $15.43.

Specifically, insider Todd DuChene sold 10,000 shares of the stock in a transaction dated Monday, October 12th. The stock was sold at an average price of $15.12, for a total value of $151,200.00. Following the completion of the sale, the insider directly owned 1,159,668 shares in the company, valued at $17,534,180.16. This represents a 0.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on CORZ. B. Riley Financial upped their price target on shares of Core Scientific from $33.00 to $42.00 and gave the company a “buy” rating in a report on Monday, August 3rd. Needham & Company LLC raised their price objective on shares of Core Scientific from $29.00 to $35.00 and gave the stock a “buy” rating in a report on Wednesday, July 29th. UBS Group restated a “market outperform” rating on shares of Core Scientific in a report on Wednesday. Citigroup reaffirmed a “market outperform” rating on shares of Core Scientific in a research report on Wednesday. Finally, BTIG Research reaffirmed a “buy” rating and issued a $38.00 price objective on shares of Core Scientific in a research report on Thursday. Two analysts have rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $31.36.

Key Headlines Impacting Core Scientific

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Analyst support strengthened: Canaccord Genuity reaffirmed a “Buy” rating with a $36 price target, while BTIG Research maintained its “Buy” rating with a $38 target. Cantor Fitzgerald also reaffirmed an “Overweight” rating and set a $39 target. These targets imply substantial upside from recent trading levels. Canaccord Genuity Core Scientific rating
• Positive Sentiment: Needham maintained its $35 target: The firm reiterated its bullish valuation even as it noted credit pressure facing Core Scientific’s tenant, CoreWeave. Continued analyst confidence supports the investment case for CORZ’s data-center and AI infrastructure expansion. Needham reiterates Core Scientific price target
• Neutral Sentiment: Upcoming earnings event: Core Scientific will release third-quarter fiscal 2026 results before the market opens on November 5 and hold a conference call at 8:30 a.m. Eastern time. Investors will look for updates on revenue, profitability, customer demand and AI data-center capacity. Core Scientific third-quarter 2026 earnings announcement
• Negative Sentiment: Insider sale adds a modest cautionary signal: Director Todd DuChene sold 10,000 shares for approximately $151,200, reducing his direct ownership by 0.85%. He still retains a substantial position, so the transaction may have limited significance, but insider selling can weigh on sentiment.
• Negative Sentiment: Tenant credit risk remains a concern: Needham’s commentary indicates that financial pressure at CoreWeave could create uncertainty for Core Scientific because of the tenant relationship, potentially affecting contract execution or investor confidence despite the maintained price target.

Core Scientific Stock Performance

The business has a 50-day simple moving average of $17.45 and a two-hundred day simple moving average of $21.05. The stock has a market cap of $4.64 billion, a price-to-earnings ratio of -3.27 and a beta of 5.49.

Core Scientific (NASDAQ:CORZ) last issued its quarterly earnings results on Tuesday, July 28th. The company reported ($3.32) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($3.26). The firm had revenue of $164.20 million for the quarter, compared to the consensus estimate of $144.83 million. On average, analysts expect that Core Scientific, Inc. will post -1.36 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Core Scientific

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CORZ. Parkside Financial Bank & Trust boosted its stake in shares of Core Scientific by 1,371.3% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,177 shares of the company’s stock worth $30,000 after buying an additional 1,097 shares during the last quarter. CoreCap Advisors LLC bought a new position in shares of Core Scientific in the 2nd quarter valued at about $36,000. Rakuten Securities Inc. bought a new position in shares of Core Scientific in the 2nd quarter valued at about $47,000. PNC Financial Services Group Inc. grew its holdings in shares of Core Scientific by 41.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 4,396 shares of the company’s stock valued at $66,000 after acquiring an additional 1,285 shares in the last quarter. Finally, GAMMA Investing LLC increased its position in shares of Core Scientific by 34.5% in the second quarter. GAMMA Investing LLC now owns 3,049 shares of the company’s stock valued at $78,000 after acquiring an additional 782 shares during the last quarter.

Core Scientific Company Profile

Core Scientific, Inc is a digital infrastructure company that develops and operates data centers in the United States. Its business has historically centered on cryptocurrency mining, particularly the processing of transactions on the Bitcoin network, while also providing hosting and infrastructure services to other mining and technology customers.

The company is expanding its data center capabilities to support high-performance computing and artificial intelligence workloads. Its services include data center operations, power and equipment management, hosting, and related infrastructure support for customers that require substantial computing capacity.

Core Scientific was founded in 2017 and became a publicly traded company through a business combination in 2022.